https://scholars.lib.ntu.edu.tw/handle/123456789/413476
標題: | IMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanoma | 作者: | YI-SHUAN SHEEN YI-HUA LIAO HSIEN-CHING CHIU SHIOU-HWA JEE CHIA-YU CHU Hsieh M.-C. Chen P.-C. Cha S.-T. YUNG-MING JENG Chang C.-C. Jee S.-H. Kuo M.-L. CHIA-YING CHU |
公開日期: | 四月-2015 | 出版社: | NATURE PUBLISHING GROUP | 卷: | 135 | 期: | 4 | 起(迄)頁: | 1065 | 來源出版物: | The Journal of investigative dermatology | 摘要: | IGF II mRNA-binding protein 3 (IMP-3) has been reported to be a marker of melanoma progression. However, the mechanisms by which it impacts melanoma are incompletely understood. In this study, we investigate the clinical significance of IMP-3 in melanoma progression and also its underlying mechanisms. We found that IMP-3 expression was much higher in advanced-stage/metastatic melanomas and that it was associated with a poor prognosis (P=0.001). Univariate analysis showed that IMP-3 expression was associated with stage III/IV melanomas (odds ratio=5.40, P=0.031) and the acral lentiginous subtype (odds ratio=3.93, P=0.0034). MeWo cells with overexpression of IMP-3 showed enhanced proliferation and migration and significantly increased tumorigenesis and metastatic ability in nude mice. We further demonstrated that IMP-3 could bind and enhance the stability of the mRNA of high mobility group AT-hook 2 (HMGA2). It was also confirmed that IMP-3 had an important role in melanoma invasion and metastasis through regulating HMGA2 mRNA expression. IMP-3 expression was positively correlated with HMGA2 expression in melanoma cells and also in melanoma tissues. Our results show that IMP-3 expression is a strong prognostic factor for melanoma, especially acral lentiginous melanoma. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/413476 | ISSN: | 0022-202X | DOI: | https://api.elsevier.com/content/abstract/scopus_id/84925455121 10.1038/jid.2014.480 |
SDG/關鍵字: | high mobility group A2 protein; messenger RNA; tissue inhibitor of metalloproteinase 3; high mobility group A2 protein; IMP3 protein, human; RNA binding protein; tumor marker; acral lentiginous melanoma; aged; animal cell; animal tissue; Article; cancer growth; cancer patient; cancer prognosis; cell invasion; cell migration; cell proliferation; controlled study; correlational study; female; follow up; gene overexpression; human; investigative procedures; major clinical study; male; melanoma; melanoma cell; metastatic melanoma; mouse; nonhuman; priority journal; protein expression; cell motion; disease course; DNA microarray; gene expression regulation; melanoma; metabolism; metastasis; prognosis; risk; skin tumor; tumor cell line; tumor invasion; Cell Line, Tumor; Cell Movement; Disease Progression; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Odds Ratio; Oligonucleotide Array Sequence Analysis; Prognosis; RNA-Binding Proteins; Skin Neoplasms; Tumor Markers, Biological |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。